396 related articles for article (PubMed ID: 30880247)
1. Cisplatin resistance involves a metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition.
Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Palacios-Zambrano S; Moreno-Villa MR; Ruiz-Valdepeñas AM; Lendinez C; Romero A; Franco F; Calvo V; Alfaro C; Acosta PM; Salas C; Garcia JM; Provencio M
Free Radic Biol Med; 2019 May; 135():167-181. PubMed ID: 30880247
[TBL] [Abstract][Full Text] [Related]
2. PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy.
Cruz-Bermúdez A; Vicente-Blanco RJ; Laza-Briviesca R; García-Grande A; Laine-Menéndez S; Gutiérrez L; Calvo V; Romero A; Martín-Acosta P; García JM; Provencio M
Sci Rep; 2017 Nov; 7(1):16661. PubMed ID: 29192176
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
4. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
Wang M; Li G; Yang Z; Wang L; Zhang L; Wang T; Zhang Y; Zhang S; Han Y; Jia L
Oncotarget; 2017 Jan; 8(5):8083-8094. PubMed ID: 28042952
[TBL] [Abstract][Full Text] [Related]
5. Glutathione Peroxidase 1 Promotes NSCLC Resistance to Cisplatin via ROS-Induced Activation of PI3K/AKT Pathway.
Chen B; Shen Z; Wu D; Xie X; Xu X; Lv L; Dai H; Chen J; Gan X
Biomed Res Int; 2019; 2019():7640547. PubMed ID: 31032363
[TBL] [Abstract][Full Text] [Related]
6. SR18292 exerts potent antitumor effects in multiple myeloma via inhibition of oxidative phosphorylation.
Xiang Y; Fang B; Liu Y; Yan S; Cao D; Mei H; Wang Q; Hu Y; Guo T
Life Sci; 2020 Sep; 256():117971. PubMed ID: 32553925
[TBL] [Abstract][Full Text] [Related]
7. Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells.
Bruns I; Sauer B; Burger MC; Eriksson J; Hofmann U; Braun Y; Harter PN; Luger AL; Ronellenfitsch MW; Steinbach JP; Rieger J
J Biol Chem; 2019 Mar; 294(9):3037-3050. PubMed ID: 30578297
[TBL] [Abstract][Full Text] [Related]
8. PGC-1α activator ZLN005 promotes maturation of cardiomyocytes derived from human embryonic stem cells.
Liu Y; Bai H; Guo F; Thai PN; Luo X; Zhang P; Yang C; Feng X; Zhu D; Guo J; Liang P; Xu Z; Yang H; Lu X
Aging (Albany NY); 2020 Apr; 12(8):7411-7430. PubMed ID: 32343674
[TBL] [Abstract][Full Text] [Related]
9. Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
Quan YH; Lim JY; Choi BH; Choi Y; Choi YH; Park JH; Kim HK
Cancer Chemother Pharmacol; 2019 Mar; 83(3):399-410. PubMed ID: 30515553
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
11. Suppression of PGC-1α Drives Metabolic Dysfunction in TGFβ2-Induced EMT of Retinal Pigment Epithelial Cells.
Shu DY; Butcher ER; Saint-Geniez M
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946753
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-induced PGC-1α Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer Cells.
Yun CW; Lee JH; Lee SH
Anticancer Res; 2019 Sep; 39(9):4865-4876. PubMed ID: 31519589
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
Salaroglio IC; Belisario DC; Akman M; La Vecchia S; Godel M; Anobile DP; Ortone G; Digiovanni S; Fontana S; Costamagna C; Rubinstein M; Kopecka J; Riganti C
J Exp Clin Cancer Res; 2022 Aug; 41(1):243. PubMed ID: 35953814
[TBL] [Abstract][Full Text] [Related]
14. Deferoxamine Counteracts Cisplatin Resistance in A549 Lung Adenocarcinoma Cells by Increasing Vulnerability to Glutamine Deprivation-Induced Cell Death.
Liu WJ; Pan PY; Sun Y; Wang JB; Zhou H; Xie X; Duan ZY; Dong HY; Chen WN; Zhang LD; Wang C
Front Oncol; 2021; 11():794735. PubMed ID: 35127502
[TBL] [Abstract][Full Text] [Related]
15. PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations.
Yao Z; Jones AW; Fassone E; Sweeney MG; Lebiedzinska M; Suski JM; Wieckowski MR; Tajeddine N; Hargreaves IP; Yasukawa T; Tufo G; Brenner C; Kroemer G; Rahman S; Szabadkai G
Oncogene; 2013 May; 32(20):2592-600. PubMed ID: 22777349
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma.
Raggi C; Taddei ML; Sacco E; Navari N; Correnti M; Piombanti B; Pastore M; Campani C; Pranzini E; Iorio J; Lori G; Lottini T; Peano C; Cibella J; Lewinska M; Andersen JB; di Tommaso L; Viganò L; Di Maira G; Madiai S; Ramazzotti M; Orlandi I; Arcangeli A; Chiarugi P; Marra F
J Hepatol; 2021 Jun; 74(6):1373-1385. PubMed ID: 33484774
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial calcium uniporter regulates PGC-1α expression to mediate metabolic reprogramming in pulmonary fibrosis.
Gu L; Larson Casey JL; Andrabi SA; Lee JH; Meza-Perez S; Randall TD; Carter AB
Redox Biol; 2019 Sep; 26():101307. PubMed ID: 31473487
[TBL] [Abstract][Full Text] [Related]
18. Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.
Wang N; Song L; Xu Y; Zhang L; Wu Y; Guo J; Ji W; Li L; Zhao J; Zhang X; Zhan L
EBioMedicine; 2019 Sep; 47():65-77. PubMed ID: 31495720
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts modify lung cancer metabolism involving ROS and TGF-β signaling.
Cruz-Bermúdez A; Laza-Briviesca R; Vicente-Blanco RJ; García-Grande A; Coronado MJ; Laine-Menéndez S; Alfaro C; Sanchez JC; Franco F; Calvo V; Romero A; Martin-Acosta P; Salas C; Garcia JM; Provencio M
Free Radic Biol Med; 2019 Jan; 130():163-173. PubMed ID: 30391585
[TBL] [Abstract][Full Text] [Related]
20. Interplay between ShcA Signaling and PGC-1α Triggers Targetable Metabolic Vulnerabilities in Breast Cancer.
Im YK; Najyb O; Gravel SP; McGuirk S; Ahn R; Avizonis DZ; Chénard V; Sabourin V; Hudson J; Pawson T; Topisirovic I; Pollak M; St-Pierre J; Ursini-Siegel J
Cancer Res; 2018 Sep; 78(17):4826-4838. PubMed ID: 29930100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
